Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients

NCT00895583 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft Rejection
Kidney Transplant
Renal Allograft Recipients
Renal Transplant

Interventions

DRUG: Tacrolimus
DRUG: Sirolimus
DRUG: Tacrolimus

Sponsor

Pfizer